Understanding Amyloid-Targeting Therapies
An overview of the amyloid beta continuum, from cleavage of the amyloid precursor protein to the deposition of neuritic plaques, with description of differential targets for investigational amyloid targeting therapies.
Date of Last Review: July 10, 2024
Document Number: VV-MED-150119
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice